Clinical controversies surrounding the diagnosis and treatment of hepatopulmonary syndrome

Minerva Anestesiologica

Volumn 73, Issue 6, 2007, Pages 347-355

  Mandell, M Susan ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Anesthesia; Diagnosis; Drug therapy; Hepatopulmonary syndrome

Indexed keywords

ANTIBIOTIC AGENT; METHYLENE BLUE; NITRIC OXIDE; OXYGEN; TUMOR NECROSIS FACTOR;

ARTIFICIAL VENTILATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; GRAM NEGATIVE INFECTION; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; LUNG ARTERIOVENOUS SHUNT; LUNG BLOOD VESSEL; MORBIDITY; MORTALITY; NONHUMAN; ORGAN DONOR; OXYGEN THERAPY; PATIENT POSITIONING; REVIEW; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANOXEMIA; HEPATOPULMONARY SYNDROME; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; PULMONARY CIRCULATION;

EID: 34547505945     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Scientific Registry of Transplant Recipients. Transplant statistics; national report, http://www.ustransplant.org/crs_0104/national.php. Accessed May 2, 2004.
2. Van Thiel D, Schade R, Gavaler J, Shaw B, Iwatsuki S, Starzl T. Medical aspects of liver transplantation. Hepatology 1984;4(Suppl):79-83.
3. Krowka M, Cortese D. Hepatopulmonary syndrome: current concepts in diagnosis and therapeutic considerations. Chest 1994;105:1528-37.
4. Agusti A, Roca J, Rodriguez-Roizen R. Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med 1996;17:49-66.
5. Kim BJ, Lee SC, Park SW, Choi MS, Koh KC, Paik SW et al. Characteristics and prevalence of intrapulmonary shunt detected by contrast echocardiography with harmonic imaging in liver transplant candidates. Am J Cardiol 2004;94:525-8.
6. Castaing Y, Manier G. Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients. Chest 1989;96: 1064-9.
7. Mandell MS. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl 2004;10:S54-8.
8. Gomez FP, Martinez-Pali G, Barbera JA, Roca J, Navasa M, Rodriguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 2004;40: 660-6.
9. Chang SW, Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome. Am Rev Respir Dis 1992;145:798-805.
10. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998;27:472-80.
11. Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998;29:571-8.
12. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats; a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003;38:556-63.
13. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367-73.
14. Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987;135:1085-92.
15. Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol 2005;28;11:567-72.
16. Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: Hhepatopulmonary syndrome. J Clin Gastroenterol 2005;39:s138-s142.
17. 99mTcMAA lung scanning. Chest 2001; 18:615-24.
18. Thorens JB, Junod AF. Hypoxemia and liver cirrhosis: a new argument in favor of a "diffusion-perfusion defect". Eur Respir J 1992; 5:754-6.
19. Lima BL, Franca AV, Pazin-Filho A, Araujo WM, Martinez JA, Maciel BC et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004;79:42-8.
20. Katsuta Y, Honma H, Zhang XJ, Ohsuga M, Komeichi H, Shimizu S et al. Pulmonary blood transit time and impaired arterial oxygenation in patient with chronic liver disease. J Gastroenterol 2005;40:57-63.
21. Aller R, Moreira V, Boixeda D, Moya JL, de Luis DA, Enriquez JL et al. Diagnosis of hepatopulmonary syndrome with contrast transthoracic echocardiography and histological confirmation. Liver 1998;18:285-7.
22. Mimdis KP, Karatza C, Spiropoulos KV, Toulgaridis T, Charokopos N, Thomopoulos KC et al. Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early cirrhosis. Scand J Gastroenterol 1998;33:988-92.
23. Krowka MJ. Pulmonary observations in α1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C and other hepatic problems. Clin Chest Med 1996;17:67-82.
24. Ruff F. Effect of age and posture on closing volume. Scand J Respir Dis Suppl 1974;85:190-200.
25. Rea HH, Withy SJ, Seelye ER, Harris EA. The effects of posture on venous admixture and respiratory dead space in health. Am Rev Respir Dis 1977;115:571-80.
26. Bruchell HB, Helmholz HF. Wood EH. Reflex orthostatic dyspnea associated with pulmonary hypertension. Am J Physiol 1949; 159:563-4.
27. Ferry TG, Naum CC. Orthodeoxia-platypnea due to diabetic autonomic neuropathy. Diabetes Care 1999;22: 857-9.
28. Guerin P, Lambert V, Godart F, Legendre A, Petit J, Bourlon F et al. Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease. J Gastroenterol 2005;40:57-63.
29. Bourke SJ, Munro NC, White JE, Gibson GJ, Ashcroft T, Cortis PA. Platypnoea-orthodeoxia in cryptogenic fibrosing alveolitis. Respir Med 1995;89:387-9.
30. Nagata T, Matsumoto A, Uehara Y, Tanaka, Oonuma H, Hara K et al. (Oxygenation abnormalities in normoxemic patients with mild liver cirrhosis. Intern Med 2002;41:435-40.
31. Edell ES, Cortese DA, Krowka MJ, Rehder K. Severe hypoxemia and liver disease. Am Rev Respir Dis 1989;140:1631-35.
32. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125: 1042-52.
33. Eldridge M, Dempsey J, Haverkamp H, Lovering A, Hokanson J. Exercise-induced intrapulmonary arteriovenous shunting in healthy humans. J Appl Physiol 2004;97:797-805.
34. Stickland MK, Welsch RC, Haykowsky MJ, Peterson SR, Anderson WD, Taylor DA et al. Intrapulmonary shunt and pulmonary gas exchange during exercise. Physiology (in Press), published on-line 2004; 5:567-79, jap.physiology.org/cgi/ external_ref?access_num=jap%3B90%2F3%2F989&link_type=ISI
35. Schraufnagel D, Kay J. Structural and pathological changes in the lung vasculature in chronic liver disease. Clin Chest Med 1996;17:1-15.
36. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-8.
37. Lange P, Stoller J. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-9.
38. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach Gastroenterology 1998;114:305-10.
39. Taille C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F et al. Liver transplantation for hepatopulmonary syndrome. A ten-year experience in Paris, France. Transplantation 2003;75:1482-9.
40. United Network for Organ Sharing. Policy 3.6.5.4.1 Liver candidates with hepatopulmonary syndrome, http;//www.unos.org/policies and bylaws/ policies/doc Accessed May 2, 2004.
41. Collisson EA, Nourmand H, Fraiman MH, Cooper CB, Bellamy PE, Farmer DG et al. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 2002;8:925-31.
42. Arguedas M, Abrams G, Krowka M, Fallon M. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-7.
43. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999;67: 712-7.
44. Lasch HM, Fried MW, Zacks SL, Odell P, Johnson MW, Gerber DA et al. Use of transjugular intraphepatic portosystemic shunts as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 2001;7:147-9.
45. Chevallier P, Noveli L, Motamedi JP, Hastier P, Brunner P, Bruneton JN. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year followup. Vasc Interv Radiol 2004;15:647-8.
46. Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB. Transjugular intrahepatic portosystemic shunt: A successful treatment for portopulmonary hypertension. Am J Gastroenterol 1998;93:455-8.
47. Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002;166:514-7.
48. Sztrymf B, Rabiller A, Nunes H, Savale L, Lebrec D, Le Pape A et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Repir J 2004;23:752-8.
49. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 2003;362:43-4.
50. Jounieaux V, Leleu O, Mayeux I. Cadiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome. Intensive Care Med 2001;27: 1103-4.
51. Poterucha JJ, Krowka MJ, Dickson ER, Corese DA, Stanson AW, Krom RA. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology 1995;21:96-100.
52. Ryu JK, Oh JH. Hepatopulmonary syndrome: angiography and therapeutic embolization. Clin Imaging 2003;27: 97-100.
53. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999; 15:712-5.
54. Taniai N, Onda M, Tajiri T, Akimaru K, Yoshida H, Mamada Y et al. Reversal of hypoxemia by inhaled nitric oxide in a child with hepatopulmonary syndrome after living-related transplantation. Transpl Proc 2002;34:2791-2.